CRYSTAL FORMS OF THE POSACONAZOLE INTERMEDIATE COMPOUND AND A METHOD FOR THE PREPARATION OF AMORPHOUS POSACONAZOLE Russian patent published in 2021 - IPC C07D405/14 

Abstract RU 2750898 C2

FIELD: drugs.

SUBSTANCE: invention relates to a one-pot method for producing amorphous form 4-[4- [4- [4 - [[(3R, 5R)-5- (2,4-difluorophenyl) tetrahydro-5 (1H-1,2,4-triazole- 1-ylmethyl) -3-furanyl] methoxy] phenyl]-1-piperazinyl]phenyl]-2-[(1S,2S)-1-ethyl-2-hydroxypropyl]-2,4-dihydro-3H-1, 2,4-triazol-3-one of formula (IV) (posaconazole), which includes a) treatment of 4-(4- (4- (4 - (((3R, 5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl) methoxy) phenyl) piperazin-1-yl)phenyl)-1-((2S,3S)-2-(benzyloxy)pentan-3-yl)-1H-1,2,4-triazole-5(4H)-one

of formula (III) with concentrated hydrochloric acid and stirring the reaction mixture at a temperature55-70°C, b) cooling the reaction mixture and introducing a halogenated hydrocarbon solvent, c) separation of layers, d) introducing a halogenated hydrocarbon solvent into the aqueous layer and adjusting the pH to 8-12, e) partial concentration of the organic layer and the possible introduction into the reaction mixture of a solvent - aliphatic ketone, f) mixing the reaction mixture of Stage e) and an aliphatic hydrocarbon solvent at a temperature 10-25°C and g) filtration and optional washing with an aliphatic hydrocarbon solvent to obtain an amorphous compound of formula IV, wherein 4-(4-(4-(4-(((3R, 5R)-5-((1H-1,2,4-triazole-1-yl)methyl)-5- (2,4-difluorophenyl) tetrahydrofuran-3-yl) methoxy) phenyl) piperazin-1yl) phenyl)-1- ((2S, 3S) -2- (benzyloxy) pentan-3-yl )-1H-1,2,4-triazol-5 (4H)-one of formula (III) is crystalline B-3 form, which is characterized by the X-ray diffractogram shown in Fig. 3. The invention also relates to crystalline form B-3 4-(4-(4-(4-(((3R, 5R)-5-((1H-1,2,4-triazol-1-yl) methyl)-5- (2,4-difluorophenyl) tetrahydrofuran-3-yl) methoxy) phenyl) piperazin-1-yl) phenyl)-1-((2S, 3S)-2-(benzyloxy) pentan-3-yl)-1H-1, 2,4-triazol-5 (4H)-one of formula (III), which is an intermediate for the preparation of amorphous posaconazole, and a method for its preparation.

EFFECT: effective method for amorphous posaconazole preparation.

5 cl, 3 tbl, 7 dwg, 9 ex

Similar patents RU2750898C2

Title Year Author Number
METHOD OF PRODUCING VORICONAZOLE 2008
  • Moon Joung-Kho
  • Li Moon Sub
  • Joo Dzae Kho
  • Kim Dzi Sook
  • Kim Khan Kiong
  • Choi Chang Dzu
  • Chang Joung Kil
  • Li Gvan Sun
RU2434009C1
DERIVATIVES OF CYCLOHEXANE OR TETRAHYDROPYRANE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, OR HYDRATES, OR SOLVATES OF THESE COMPOUNDS, OR THEIR SALTS, INTERMEDIATE COMPOUNDS FOR THEIR SYNTHESIS AND FUNGICIDE AGENT 1992
  • Jukhko Aoki[Jp]
  • Khiromichi Kotaki[Jp]
  • Katsunao Masubuchi[Jp]
  • Toru Okuda[Jp]
  • Nobuo Shimma[Jp]
  • Takuo Tsakuda[Jp]
  • Isao Umeda[Jp]
RU2084439C1
METHOD OF SYNTHESIS OF TRIAZOLES, ULTIMATE AND INTERMEDIATE COMPOUNDS OF METHOD 1996
  • Majkl Batters
  • Dzhuli Ehnn Kharrison
  • Alan Dzhon Pettman
RU2156760C2
NEW PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AND APPLICATION THEREOF 2014
  • Van Yun
  • Chzhao Liven
  • Chzhan Syan
  • Bi Shen
  • Gao Ipin
  • Chen Khunyan
  • Van Dechzhun
  • Nan Yan
  • Chzhan Tsan
  • Li Yujsyu
  • Chzhan Di
RU2621709C2
METHOD FOR PREPARING VORICONAZOLE AND ITS ANALOGUES 2013
  • Barrel Adam Dzhejms Masgrejv
  • O'Nejl Pedrejg Meri
  • Pettman Alan Dzhon
RU2619928C2
AZOLE COMPOUNDS, METHOD OF THEIR SYNTHESIS, ANTIFUNGAL PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF FUNGAL INFECTION 1998
  • Itokh Katsumi
  • Kitazaki Tomojuki
  • Okonogi Kendzi
RU2189982C2
N-(1-(1-BENZYL-4-PHENYL-1H-IMIDAZOL-2-YL)-2,2-DIMETHYLPROPYL)-BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS KINESIN SPINDLE PROTEIN (KSP) INHIBITORS FOR TREATING CANCER 2005
  • Vang Vejbo
  • Bersehnti Pol A.
  • Ksi Ji
  • Bojse Rustum S.
  • Pekki Sabina
  • Brehmmajer Natan
  • Fillips Megan
  • Mendenkholl Kris
  • Vejmehn Kelli
  • Lehgnajton Lajena Mehri
  • Konstehntajn Rajan
  • Jang Khong
  • M'Juli Ehlizabet
  • Ramurtkhi Savitri
  • Dzhejzen Ehlajza
  • Sharma Anu
  • Rama Dzhain
  • Sabramanian Sharadkha
  • Renkhoui Pol
  • Behr Kennet Uolter
  • Djul Dehvid
  • Val'Ter Annette
  • Ehbrems Tajnija
  • Khukh Kaj
  • Martin Ehrik
  • Knehpp Mark
  • Le Vinsent
RU2427572C2
NEW CRYSTALLINE FORM OF 2-{3-[2-(1-{[3,5-BIS(DIFLUOROMETHYL)-1H-PYRAZOL-1-YL]ACETYL}PIPERIDIN-4-YL)-1,3-THIAZOL-4-YL]-4,5-DIHYDRO-1,2-OXAZOL-5-YL}-3-CHLOROPHENYLMETHANE SULPHONATE 2014
  • Olenik Britta
  • Khillebrand Shtefan
  • Vasner Perr
  • Vajss Martin
  • Vakhendorff-Nojmann Ulrike
RU2691948C2
COMBINED TREATMENT BY A TOLL-LIKE RECEPTOR (TLR7) AGONIST AND A HEPATITIS B VIRUS CAPSID ASSEMBLY INHIBITOR 2016
  • Daj, Lue
  • Gao, Lu
RU2718917C2
SYNTHETIC INTERMEDIATE COMPOUND 1-(2-DESOXY-2-FLUORO-4-THIO-β-D-ARABINOFURANOSYL)CYTOSINE, SYNTHETIC INTERMEDIATE THIONUCLEOSIDES COMPOUND AND METHOD FOR THEIR PRODUCTION 2013
  • Nakamura Kouki
  • Simamura Satosi
  • Imoto Dzuniti
  • Takakhasi Motomasa
  • Vatanabe Katsuyuki
  • Vada Kendzi
  • Fudzino Yuuta
  • Matsumoto Takuya
  • Takakhasi Makoto
  • Okada Khideki
  • Yamane Takekhiro
  • Ito Takayuki
RU2633355C2

RU 2 750 898 C2

Authors

Charyulu Palle Venkata Ragkhavendra

Gouda Dkharshan Dzhakkali Chandre

Radzhmakhendra Shanmugkhasami

Raman Manikandan

Dates

2021-07-05Published

2016-09-22Filed